Abstract
Comparison of a one-sample with a multi-sample method (the metabolic fractional clearance) to estimate CYP2E1 activity in humans. Healthy, male Caucasians (n=19) were included. The multi-sample fractional clearance (Clfe) of chlorzoxazone was compared with one-time-point clearance estimation (Clest) at 3, 4, 5 and 6 h. Furthermore, the metabolite/drug ratios (MRs) estimated from one-time-point samples at 1, 2, 3, 4, 5 and 6 h were compared with Clfe. The concordance between Clest and Clfe was highest at 6 h. The minimal mean prediction error (MPE) of Clest as a percentage of actual mean Clfe was −4.2% at 6 h. Furthermore, regarding Clfe, there was a negligible difference (P=0.56) of bias between Clest at 3 h (MPE=−8.9%) and 6 h (MPE=−4.2%). The best concordance between MR and Clfe was found at 3 h (r=0.74; Pest at 3 h or 6 h, and MR at 3 h, can serve as reliable markers of CYP2E1 activity. The one-sample clearance method is an accurate, renal function-independent measure of the intrinsic activity; it is simple to use and easily applicable to humans.

This publication has 11 references indexed in Scilit: